Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

FIBRIN FILM TREATMENT OF CORNEAL DISEASES

FIBRIN FILM TREATMENT OF CORNEAL DISEASES Abstract WE CONSTANTLY search for new or improved medication which will relieve pain and speed healing. In treating corneal diseases we often partially defeat one purpose to accomplish another. Some of our commonly used agents, for example, tetracaine and hydrous wool fat U. S. P. (lanolin), while relieving pain or serving as a vehicle, may delay corneal healing. If we can find an agent which both relieves pain and stimulates or supports healing, we shall come close to an ideal medicine for treating corneal disease. In thromboplastin we have such an agent. When properly used, it relieves pain quickly and permits rapid replacement of corneal epithelium. My colleagues and I have used it in the treatment of about 100 corneal lesions of various types, with very satisfying clinical results. We have also attempted to verify the work in laboratory animals, with some encouraging and stimulating experiments. The material we used in References 1. Parke, Davis & Company, Thrombin Topical (bovine origin), 5 cc. 2. Sharp & Dohme, Inc., Lyovac Normal Human Plasma. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Ophthalmology American Medical Association

FIBRIN FILM TREATMENT OF CORNEAL DISEASES

A.M.A. Archives of Ophthalmology , Volume 51 (5) – May 1, 1954

Loading next page...
 
/lp/american-medical-association/fibrin-film-treatment-of-corneal-diseases-NHGX94ewMg

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1954 American Medical Association. All Rights Reserved.
ISSN
0096-6339
DOI
10.1001/archopht.1954.00920040691012
Publisher site
See Article on Publisher Site

Abstract

Abstract WE CONSTANTLY search for new or improved medication which will relieve pain and speed healing. In treating corneal diseases we often partially defeat one purpose to accomplish another. Some of our commonly used agents, for example, tetracaine and hydrous wool fat U. S. P. (lanolin), while relieving pain or serving as a vehicle, may delay corneal healing. If we can find an agent which both relieves pain and stimulates or supports healing, we shall come close to an ideal medicine for treating corneal disease. In thromboplastin we have such an agent. When properly used, it relieves pain quickly and permits rapid replacement of corneal epithelium. My colleagues and I have used it in the treatment of about 100 corneal lesions of various types, with very satisfying clinical results. We have also attempted to verify the work in laboratory animals, with some encouraging and stimulating experiments. The material we used in References 1. Parke, Davis & Company, Thrombin Topical (bovine origin), 5 cc. 2. Sharp & Dohme, Inc., Lyovac Normal Human Plasma.

Journal

A.M.A. Archives of OphthalmologyAmerican Medical Association

Published: May 1, 1954

There are no references for this article.